$1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth This Much
Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 19.11% on an annualized basis producing an average annual return of 32.41%. Currently, Cassava Sciences has a market capitalization of $874.09 million.
Benzinga’s Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks.
23 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss.
Cassava Sciences Shares Fall 23% Premarket; The New York Times Reported Monday Several Studies Related to the Companies Alzheimer’s Treatment Were Retracted or Questioned by Scientific Journals
https://www.nytimes.com/2022/04/18/health/alzheimers-cassava-simufilam.html
51 Biggest Movers From Yesterday
Gainers
Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown in culture.
This Is What Whales Are Betting On Cassava Sciences
A whale with a lot of money to spend has taken a noticeably bullish stance on Cassava Sciences.
Looking at options history for Cassava Sciences (NASDAQ:SAVA) we detected 14 strange trades.